PPARA and metabolic dysfunction-associated steatotic liver disease: CB n‐hexane extracts demonstrated significant hepatoprotective and metabolic regulatory effects in HFD‐induced NAFLD in rats, potentially mediated through modulation of PPAR and AMPK pathways.